The targeted removal of TXNRD1 in a mouse lung cancer cell line, LLC1 cells, resulted in the cells reversing many of their malignant properties to those more similar to normal cells, including a dramatic reduction in tumorigenic and metastatic properties [36]. Here, TXNRD1 is linked to lung carcinoma.